Loading...
XSHE
002901
Market cap2.36bUSD
Jul 15, Last price  
41.61CNY
1D
9.99%
1Q
25.48%
IPO
136.75%
Name

Double Medical Technology Inc

Chart & Performance

D1W1MN
P/E
286.90
P/S
11.04
EPS
0.15
Div Yield, %
0.60%
Shrs. gr., 5y
1.07%
Rev. gr., 5y
14.69%
Revenues
1.53b
+6.90%
202,654,587298,891,503391,825,235462,663,858594,014,625772,469,5291,257,317,9981,586,860,2091,994,333,8251,434,099,1801,533,121,281
Net income
59m
-36.28%
96,812,045139,289,565188,507,182219,328,243295,556,287371,453,093465,490,905605,684,140673,309,41392,555,27658,972,461
CFO
74m
-42.50%
106,507,183151,116,863123,443,347207,128,436308,700,299334,876,268433,877,268555,769,602673,261,691128,444,75073,861,966
Dividend
Jun 24, 20240.25 CNY/sh

Profile

Double Medical Technology Inc. provides services, technologies, and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery in China. It also exports its products to approximately 50 countries and regions, including European Union, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was founded in 2004 and is based in Xiamen, the People's Republic of China.
URL
http://www.double-medical.com/
IPO date
Sep 22, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,533,121
6.90%
1,434,099
-28.09%
Cost of revenue
1,210,320
1,292,463
Unusual Expense (Income)
NOPBT
322,801
141,637
NOPBT Margin
21.06%
9.88%
Operating Taxes
13,405
38,228
Tax Rate
4.15%
26.99%
NOPAT
309,396
103,408
Net income
58,972
-36.28%
92,555
-86.25%
Dividends
(9,431)
(208,458)
Dividend yield
0.06%
1.48%
Proceeds from repurchase of equity
411,824
BB yield
-2.92%
Debt
Debt current
316,130
7,720
Long-term debt
283,081
73,760
Deferred revenue
50,129
48,677
Other long-term liabilities
1
1
Net debt
(1,061,828)
(1,269,864)
Cash flow
Cash from operating activities
73,862
128,445
CAPEX
(305,717)
Cash from investing activities
(519,941)
Cash from financing activities
496,204
245,157
FCF
120,516
(243,073)
Balance
Cash
1,661,039
1,351,345
Long term investments
2
Excess cash
1,584,383
1,279,640
Stockholders' equity
1,792,043
2,138,756
Invested Capital
2,214,736
1,912,528
ROIC
14.99%
6.10%
ROCE
8.49%
4.43%
EV
Common stock shares outstanding
421,232
414,020
Price
40.59
19.28%
34.03
-31.78%
Market cap
17,097,801
21.35%
14,089,084
-29.95%
EV
16,138,142
12,925,874
EBITDA
434,697
237,146
EV/EBITDA
37.13
54.51
Interest
7,159
3,097
Interest/NOPBT
2.22%
2.19%